Citation: Priscilla Charmaine Kwade, Benjamin Kweku Lugu, Sadia Lukman, Carl Edem Quist, Jianxun Chu. Farmers’ attitude towards the use of genetically modified crop technology in Southern Ghana: The mediating role of risk perception[J]. AIMS Agriculture and Food, 2019, 4(4): 833-853. doi: 10.3934/agrfood.2019.4.833
[1] | Elisa Isopi, Giuseppe Legname . Pin1 and neurodegeneration: a new player for prion disorders?. AIMS Molecular Science, 2015, 2(3): 311-323. doi: 10.3934/molsci.2015.3.311 |
[2] | Amena W. Smith, Swapan K. Ray, Arabinda Das, Kenkichi Nozaki, Baerbel Rohrer, Naren L. Banik . Calpain inhibition as a possible new therapeutic target in multiple sclerosis. AIMS Molecular Science, 2017, 4(4): 446-462. doi: 10.3934/molsci.2017.4.446 |
[3] | Laetitia Weinhard, Paolo d'Errico, Tuan Leng Tay . Headmasters: Microglial regulation of learning and memory in health and disease. AIMS Molecular Science, 2018, 5(1): 63-89. doi: 10.3934/molsci.2018.1.63 |
[4] | Ashok Chakraborty, Anil Diwan . Molecular mechanisms of neurodegenerative disease (NDD). AIMS Molecular Science, 2023, 10(3): 171-185. doi: 10.3934/molsci.2023012 |
[5] | Aliya I Sani, Zil-e-Rubab, Shumaila Usman, Syed Zaryab Ahmed, Mervyn Hosein . Role of OX40 and its ligand as costimulatory modulators in cancer immunotherapy. AIMS Molecular Science, 2021, 8(3): 161-173. doi: 10.3934/molsci.2021012 |
[6] | J.R. Calvo, M.D. Maldonado . The role of melatonin in autoimmune and atopic diseases. AIMS Molecular Science, 2016, 3(2): 158-186. doi: 10.3934/molsci.2016.2.158 |
[7] | Souravh Bais, Renu Kumari, Nirmal Dongre, Aakash Singh Panwar . Insights into neurometabolic diseases. AIMS Molecular Science, 2024, 11(2): 116-139. doi: 10.3934/molsci.2024008 |
[8] | Tara P. Hurst, Caroline Coleman-Vaughan, Indu Patwal, Justin V. McCarthy . Regulated intramembrane proteolysis, innate immunity and therapeutic targets in Alzheimer’s disease. AIMS Molecular Science, 2016, 3(2): 138-157. doi: 10.3934/molsci.2016.2.138 |
[9] | Rahel Tekeste, Gregorio Garza, Song Han, Jianli Dong . Ticagrelor is more effective than clopidogrel in carrier of nonfunctional CYP2C19 allele who has diabetes and acute coronary syndrome - case report and literature review. AIMS Molecular Science, 2022, 9(2): 66-78. doi: 10.3934/molsci.2022004 |
[10] | Naba Hasan, Waleem Ahmad, Feroz Alam, Mahboob Hasan . Ferroptosis-molecular mechanisms and newer insights into some diseases. AIMS Molecular Science, 2023, 10(1): 22-36. doi: 10.3934/molsci.2023003 |
Prion diseases consist of a group of transmissible neurodegenerative disorders which affect animal as well as human species (Scrapie, Bovine Spongiform Encephalopathy (BSE) or chronic wasting disease; and Creutzfeldt Jakob disease (CJD), Gerstmann-Straussler-Schienker (GSS), Fatal Familial Insomnia or kuru, respectively). To date it has been impossible to develop preventive and/or palliative treatments against these pathologies; then, they possess an unavoidably lethal final. A protease-resistant form, conformationally altered, of the prion protein (PrPc) termed PrPsc is considered critical for this group of diseases. In fact, the prion protein as aetiological agent causing this group of diseases is the most accepted theory since it was postulated by Prusiner SB in 1982. PrPc exists in healthy animal cells while they are attached to cell membrane [1]. It is considered that this protein is cytotoxic in its unbound state, when it is accumulated in cytosol [2]. Since the brain is less efficient than other animal organs in its ability to remove abnormal molecules, PrPsc can be found accumulated in this kind of diseases.
While most authors claim this protein as infectious itself [3,4,5,6,7,8] some others postulate it as consequent feature [9,10,11]. The possibility of this protein as triggering of a host response which might cause the neurodegeneration may constitute an alternative hypothesis, not only for prion but also for other neurodegenerative disorders. Despite prion theory is the most widely spread some authors have proposed that the misfolded protein is probably the result of evolution of a self-defence reaction. Axelrad [9] suggests that any T-cells that recognize anchor PrP, in the absence of initiating chemicals, would enter a state of immunotolerance to the protein; only when immune response is either experimentally or accidentally triggered by unbound PrP, devastation of tissue begins. Differences in treatment of PrP by the host protective system could explain those cases where prion disease-like symptoms can be transmitted to mice in the absence of detectable abnormal prion protein [10] or why up to 25% of cows with suspected BSE possess no spongiform symptoms at autopsy, probably due to resistant genotypes [9].
An autoimmune response may even represent a supported theoretical hypothesis for these diseases [11], because it makes possible to explain some of these difficult unsolved questions. The interactions between astrocytes and oligodendrocytes observed by Liberski et al. [12] in CJD and Scrapie infected mice may support this possible autoimmune response, due to that the association of these cells does not seem to be associated with a reaction towards any infectious pathogen. Rather, they may also represent an early cellular event that triggers further brain tissue destruction. This could be mediated by pro-inflammatory cytokines secreted by astrocytes, lymphocytes and macrophages. It had been already suggested that TNFa secreted by astrocytes may be responsible for some brain tissue destruction encountered in prion diseases [13]. And it is important to point out that both TNFα and its mRNA are massively up-regulated toward terminal stage of experimental CJD in mice [14,15]. But moreover, not only astrocytes are the only source of cytokines in prion diseases, but also microglial cells [16]. Microglia, the main phagocytic cell in central nervous tissue which are associated with the pathogenesis of many neurodegenerative and brain inflammatory diseases [17], have been demonstrated to serve as sensitive indicator of local neuronal damage predicting degeneration of neurons [18]. It is known to be present in Scrapie affected mouse brains and even to be a component of amyloid plaques in kuru, CJD and GSS [19,20]. However, although all these data lend support to the hypothesis that this glial population is clearly involved in the pathogenesis of CJD, its expression/alteration has been studied in only some murine Scrapie models [21] and few CJD cases [22,23]. In addition, it results interesting to mention that pro-inflammatory cytokines have been implicated in pathogenesis of multiple sclerosis, a neurodegenerative disorder whose source is accepted to be autoimmune. Otherwise, very insufficient efforts have been made to deepen on this possible immunological involvement regarding neurodegenerative diseases.
Furthermore, several groups have shown evidences of humoral immune responses in prion diseases. Gadjusek's group found that sera from Scrapie affected sheep were reactive mainly to neurofilament protein preparations from mouse brain [24]. Increased levels of antibodies to bovine myelin basic protein, neurofilament and prion antigens were also detected in BSE animals [25,26], as well as of IgG, IgA and C3 in the cerebrospinal fluid and IgA in serum belonging to CJD patients [17]. And CJD and kuru patients have shown elevated values of myelin basic protein auto-antibodies [28] and anti-neurofilament antibodies [29]. Additionally, the inoculation with prion disease affected brains has failed to produce clinical disease when cells B were absent [30]. Accumulation and activation of microglial cells have been observed in prion affected animals and CJD patients [31], and elevated plasma levels of C reactive proteins and IL6 cytokines, both indicative of ongoing inflammation somewhere, have been detected in CJD [32]. Besides, Hu et al. [33] revealed PrPc as a molecule critically influencing T cell functions, by modulating TCR signals and limiting survival.
An amazing aspect of prion diseases is the fact that they are accepted to be associated to some different types or strains [34,35,36]. Strain typing based on the differences among PrPsc glycoforms and this glycosylation proportions have been determined. Nevertheless, just those establishing differences among human CJD types [37] and BSE and natural Scrapie affected sheep [38] have been extended and routinely applied afterwards because inconsistent results are provided in many occasions. Moreover, even regarding human subtypes which are quite well established, variability is also observed depending on the methodology applied. In fact, two similar but not identical classifications, Parchi and Gambetti's and Collinge's, are currently accepted. Since, according to the "only protein" theory, prion consists of an agent lacking in nucleic acid, prion strains differentiation is based on their phenotypical features determination. Additionally, it is accepted that for the identification and characterization of a strain it is strictly necessary a bioassay using murine models; however, it depends on the murine line, and some other additional factors, some strains inoculated can behave in disagreeing manners and present different molecular and/or phenotypical profiles. All these observations appear to be supporting the responsibility of host processing to determine the molecular profile in each human or animal case.
With regards to transmissibility, despite all enormous attempts mainly made focused on in vivo diagnostic purposes in order to provide repetitive and conclusive results, infectivity has been demonstrated in samples such as blood [39,40], where no PrPsc has been detected to date. Other disagreeing results have been, and continue being provided depending on the model and the protocol designed. While some authors have described infectivity of a tissue or biological fluid in all cases, some others conclude that no risk at all is shown in it [41]. But moreover, it is advisable not to forget that these studies about transmissibility in these pathologies have been based on the inoculation of nervous central system homogenates (and not purified prion protein). Therefore, some other antigens capable to initiate the individual's immune response could be also present in these homogenates.
On the other hand, although not many efforts have been made to go into this topic in greater depth, an interaction of agent and host influencing in the development of the disease has been suggested [42]. In fact, gliosis constitutes one of the histopathological changes typically found in the brains of human and animal cases joint to neuronal degeneration and deposit of pathological prion protein, but scarce relevance has been certainly pinpointed to the components of this cellular population in the pathogenesis of prion diseases until the recent hypothesis about neuroinflammation regarding neurodegenerative diseases. With the aim of demonstrating which role these glial cells are playing in the pathogenesis of the prion disease, first studies have been developed on the natural model of Scrapie, demonstrating the indisputable involvement of astroglia in prion progression by showing specific changes of this glial population matching up to the evolution of the disease [43] and which can sustain active prion propagation [44]. Moreover, experimental studies using primary cellular cultures have recently demonstrated that glial cells respond to prion infection through Toll-like receptor mediated innate immunity [45]. These findings as a whole suggest that drawing interactions between microglia and astrocytes may hold an important key to understand neuroinflammation in prion and other neurodegenerative disorders. It might also open up new immunotherapeutic strategies.
Therefore, it seems to be concluded that all these observations strongly suggest that components of neuroglia in charge of brain protection could perform a crucial role in the pathogenesis of prion diseases. It could be even therefore speculated that the differences in the development and progression of the disease expressed by different neurodegenerative courses, may lie in differences in the MHC class Ⅱ epitope presentation in the central nervous tissue [46]. So, the expression of different phenotypical profiles above referred as subtypes or strains could be associated to the different progress of the individual's protective reaction against the antigen. In fact, to determine whether a specific MHC class Ⅱ epitope is expressed in a higher percentage of CJD and Scrapie cases would constitute an interesting contribution to support the immune hypothesis, due to that it is well known that this frequently happens in immunity disorders. In fact, a very recently published study has even suggested that misfolded proteins rescued from protein degradation by MHC class Ⅱ molecules are recognized as "neo-self" antigens by immune system and constitute autoantibody targets [47].
Further deciding evidence that supports an actual role for host defence system in the onset of prion diseases are those showing in Magri et al. [48]. Their results not only showed an increased amount of pro-inflammatory cytokines in infected compared to uninfected animals, but also suggest that immunization achieved in mice using synthetic oligopeptides homologous to hamster prion protein significantly reduces inflammation. Therefore, the protective effect of the vaccination seems to be due to the consequent inflammation reduction. The proposal elaborated by De Luigi et al. [49] indicating that tetracyclines might have therapeutic potential for animals and humans against prion diseases, confers another contribution for supporting the relevance of the inflammation in the development of prion diseases. The authors suggest that these antibiotics reduce prion infectivity through a direct interaction with PrPsc potentially inactivating BSE and variant CJD (v-CJD) contaminated products [50]. However, it exists the possibility of that their evidenced efficiency is caused due to the anti-inflammatory effect presented by this family of antibiotics [51] more than the direct interaction of antibiotic with PrPsc. In fact, it has been proved to have effect on diseases where no infectious agent is involved [52]. Additionally, several studies have been published concerning the neuroprotector and neuroinflammatory effect of some tetracyclines in neurological diseases. The neuroprotector effect seems to be based on the inhibition of apoptosis by caspase-dependent mechanism [53]; meanwhile, the anti-inflammatory effect is thought to be due to the microglia modulation, by decreasing the consequent inflammatory mediator expression [54].
As it is recently accepted that inflammation represents a common denominator among a diverse list of neurodegenerative diseases, it seems to be implicated as a critical mechanism responsible for the progressive nature of neurodegeneration. Neuroinflammation itself is considered either causative or at least, contributory to the pathogenesis of neurodegeneration [55]. Since there are few therapies for the wide range of neurodegenerative diseases, scientists are still in search of new therapeutic approaches to the problem. Prostaglandins and cytokines, such as interleukin-1 (IL-1) and interleukin-6 (IL-6), have been implicated in the aetiopathology of various inflammatory and degenerative disorders, including Alzheimer's disease (AD) and prion diseases [56]; therefore, an early contribution of neuroprotective and anti-inflammatory strategies for these disorders seems particularly desirable, maybe more effective than other treatments against neurodegeneration (irreversible process, as it is known).
Concerning the possible stimulus which could trigger an exacerbated immune response, some researchers have named as possible candidate the Phosmet, an organophosphate pesticide [57]. But this theory is difficult to sustain since Scrapie has been known some hundreds of years before the discovery of organophosphates by the chemical industry [11]. In fact, an experimental study to elucidate the role of some organophosphates in the source of prion diseases, finally provided results which discarded this hypothesis [58].
For some authors, microbe agents such as Acinetobacter or Pseudomonas could be the antigen causing this initial response. These bacteria might have evoked prion diseases through the mechanism of molecular mimicry and autoimmunity in similar way to Streptococcus microbes producing rheumatic fever and Sydenham's chorea. The proposed pathogenic mechanism is that susceptible patients when exposed to repetitive or high load of the bacteria would produce increased levels of antibodies to the bacterial antigenic molecules as well as auto-antibodies to the cross-reacting brain antigens. The end result of these immunological reactions is inflammation, degeneration, axonal damage and vacuolation in the affected areas [59]. In fact, it is known that Acinetobacter is a microbe containing molecular sequences which resemble those found in neurofilaments of the brain tissue and therefore, some authors suggest that both can be sharing some epitope [60] causing the cross-reaction. A possible mechanism of how TSEs could be produced is illustrated by the human arthritic disorder ankylosing spondylitis, an autoimmune disease where high titres of auto-antibodies are evoked by the presence of Klebsiella in bowel flora. In the same manner, the inclusion of intestinal contents in green offal material in the framework of the undisputed introduction of meat and bone meal preparation in the foodstuff of cattle in early 1980s is very likely to be a source of the many microorganisms found in the soil reservoir, especially Acinetobacter and their antigens [61]. Repeated infections with these bacteria would evoke an immune response to the cross-reactive neuronal auto-antigens with the resultant pathological lesions. They would be mainly due to the effects of antibody-triggered, complement-mediate cytolytic or cytotoxic immune activity. Tissue distributions and the characteristics of the lesions may vary considerably; spite of the causes are not exactly known, it could be due to influence of other environmental and genetic factors [11]. Even more, similarities and differences demonstrated between pathological lesions in experimental autoimmune encephalomyelitis, multiple sclerosis and prion diseases could be explained by different auto-antibodies against a group of heterogeneous self-antigens homologous with antigens present in some bacterial agents (such as Acinetobacter or Pseudomonas). All these links may unveil the possibility that induction of prion diseases in animals inoculated with brain tissue could be due to an exacerbated immune response to injected brain antigens [11]. It is essential to keep in mind that central nervous tissue is known to express the largest variety of proteins in the body [62].
Some other relevant contributions which have mainly served to emerge the proposal about the relevance of host are for instance, the fact that it has been widely assumed that consumption of meat from BSE-affected animals may have caused death in about 200 v-CJD cases diagnosed to date (National CJD Surveillance Unit). However, nutritional studies carried out by this Surveillance Unit have failed to show higher meat consumptions in v-CJD patients compared to controls. Even the description of v-CJD in patients who had been vegetarians for a number of years was epidemiologically evaluated. These findings should have raised doubts, but the theory based on the consumption of meat-bone meal as the vehicle of transmission of v-CJD to humans and BSE epidemics (the bovine infectious variant of prion diseases), remains the most accepted theory.
Finally, it is important to remark that studies have been increasingly published showing more and more neurodegenerative diseases affecting, progressing and behaving in a similar way than prion diseases. Alzheimer's, Parkinson's and Huntington's diseases, frontotemporal dementia or amyotrophic lateral sclerosis are currently thought to be caused by prions [63] and are called prion-like diseases, indeed.
Specifically, Alzheimer's disease as the most worldwide common prion-like disorder occupies a similar spectrum of symptomatic pathologies with prion-mediated encephalopathies. They are both dementing disorders involving deposition of extracellular protein aggregates with associated neurodegeneration, characterized by a cascade of events that end with extracellular deposition of amyloid-β (Aβ) or PrPsc fibrillar peptides, respectively. CJD risk, as with Alzheimer's disease, is usually increased by the APOE4 allele [64,65]. Meanwhile, APOE2 allele lowers the risk of both of them. Moreover, there is an association between homozygosis at PRNP codon 129 (Met versus Val) and early onset Alzheimer's disease [66,67]. According to biochemical and histological studies, APOE possesses binding affinity for Aβ and PrP and is associated with Aβ plaques of Alzheimer's disease brain and kuru-like plaques [68,69]. Furthermore, it co-purifies with the protease-resistant core of PrP (PrP27-30) extracted from brains of hamsters with experimental Scrapie [70]. And a final relevant coincidence is that oligomeric Aβ possesses infectious prion-like features under certain situations, inducing cerebral β-amyloidosis and associated pathology in transgenic mice by intra-cerebral administration of exogenous Aβ-containing brain extracts from human with Alzheimer's disease [71,72]. Additionally, patients where both pathologies were found have been also reported [73].All these findings, further those showing that both PrPsc and Aβ preferentially bind PrPc as oligomers, raise suspicion of a common downstream mechanism, even suggesting these two neurodegenerative stimuli competing for pathway modulation [74].
Concerning the role of neuroglial cells in Alzheimer's disease, it is being dealt with not long ago [75,76,77]. And results support the hypothesis presented here. Specifically, some authors point out the novel NG2 as glial cells playing an important role in this neurodegenerative disease pathogenesis [78] based on their highly proliferative ability and capacity to regeneration of neurons and astrocytes in adult cortex [79]. But moreover, similar findings have been consistently found in patients suffering CJD and Alzheimer's disease when the involvement of astroglia was comparatively assessed in both neurodegenerative processes [80]. Additionally, a relationship between both microglia and astroglia has been just suggested to induce neuron death in various neurodegenerative disorders such as Alzheimer's, Parkinson's or Huntington's diseases, amyotrophic lateral sclerosis and multiple sclerosis [81].
By this evidenced analogy of prion-like with prion diseases, all advances attained in the frame of therapeutical approach result especially relevant, not only for prion disease study, but also for other prion-like diseases. More supporters are nowadays gaining the hypothesis which postulates that they all share molecular basis and mechanisms of propagation. Consequently, in case the involvement of host defence system is indisputably confirmed in prion pathogenesis, the design of new therapeutic alternatives for all these neurodegenerative diseases is feasible.
The author thanks Jay P. Esclapes for his professional assistance in language.
The author declares no conflict of interest.
[1] | Kwade C, Gadabu A, Addo V, et al. (2018) Genetic engineering development and acceptance in Sub Saharan Africa: Stakeholders and public opinion about GMO. J Appl Agric Econ Policy Anal 1: 22-30. |
[2] | Jayne T, Govereh J, Mwanaumo A, et al. (2002) False promise or false premise? The experience of food and input market reform in Eastern and Southern Africa. World Dev 30: 1967-1985 |
[3] |
Sarcheshmeh EE, Bijani M, Sadighi H (2018) Technology in Society Adoption behavior towards the use of nuclear technology in agriculture: A causal analysis. Technol Soc 55: 175-182. Available from: https://doi.org/10.1016/j.techsoc.2018.08.001. doi: 10.1016/j.techsoc.2018.08.001
![]() |
[4] | Bailey R, Willoughby R, Grzywacz D (2014) On trial: Agricultural biotechnology in Africa. Energy Environ Resour 1-27. |
[5] |
Qaim M, Kouser S (2013) Genetically modified crops and food security. PloS one 8: e64879. doi: 10.1371/journal.pone.0064879
![]() |
[6] | Séralini GE, Clair E, Mesnage R, et al. (2012) RETRACTED: Long term toxicity of a Roundup herbicide and a Roundup-tolerant genetically modified maize. Food Chem Toxicol 4221-4231. Available from: http://dx.doi.org/10.1016/j.fct.2012.08.005. |
[7] |
Adenle AA, Morris EJ, Parayil G (2013) Status of development, regulation and adoption of GM agriculture in Africa: Views and positions of stakeholder groups. Food Policy 43: 159-166. Available from: https://doi.org/10.1016/j.foodpol.2013.09.006. doi: 10.1016/j.foodpol.2013.09.006
![]() |
[8] | Rosegrant MW, Koo J, Cenacchi N, et al. (2014) Food security in a world of natural resource scarcity: The role of agricultural technologies. In: International Food Policy Research Institute, Washington, DC, USA. |
[9] | Rogers EM, Singhal A, Quinlan MM (2003) Diffusion of innovations/Everett M. Rogers. NY: Simon and Schuster, 576. |
[10] |
Costa-Font M, Gil JM, Traill WB (2008) Consumer acceptance, valuation of and attitudes towards genetically modified food: Revies and implications for food policy. Food Policy 33: 99-111. doi: 10.1016/j.foodpol.2007.07.002
![]() |
[11] |
Mannan S, Nordin SM, Rafik-Galea S, et al. (2017) The ironies of new innovation and the sunset industry: Diffusion and adoption. J Rural Studies 55: 316-322. doi: 10.1016/j.jrurstud.2017.07.015
![]() |
[12] |
Ueland Ø, Gunnlaugsdottir H, Holm F, et al. (2012) State of the art in benefit-risk analysis: Consumer perception. Food Chem Toxicol 50: 67-76. doi: 10.1016/j.fct.2011.06.006
![]() |
[13] | Rogers E (2003) Diffusion of innovations. New York: A Division of Simon and Schuster. |
[14] | Ghane F, Samah BA, Ahmad A, et al. (2011) The role of social influence and innovation characteristics in the adoption of Integrated Pest Management (IPM) practices by paddy farmers in Iran. In: International Conference on Social Science and Humanity-IPEDR Singapore. |
[15] | Peshin R, Vasanthakumar J, Kalra R (2009) Diffusion of innovation theory and integrated pest management. Integr Pest Manage: Dissemination Impact: 1-29. Springer, Dordrecht. Available from: https://doi.org/10.1007/978-1-4020-8990-9. |
[16] |
Robertson MJ, Llewellyn RS, Mandel R, et al. (2012) Adoption of variable rate fertiliser application in the Australian grains industry: Status, issues and prospects. Precis Agric 13: 181-199. doi: 10.1007/s11119-011-9236-3
![]() |
[17] |
Hirunyawipada T, Paswan AK (2006) Consumer innovativeness and perceived risk: Implications for high technology product adoption. J Consum Mark 23: 182-198. doi: 10.1108/07363760610674310
![]() |
[18] | Taylor JW (1974) The role of risk in consumer behavior: A comprehensive and operational theory of risk taking in consumer behavior. J Mark 38: 54-60. |
[19] |
Gupta N, Fischer AR, Frewer LJ (2012) Socio-psychological determinants of public acceptance of technologies: A review. Public Understanding Sci 21: 782-795. Available from: http://dx.doi.org/10.1177/0963662510392485. doi: 10.1177/0963662510392485
![]() |
[20] | Kim RB (2012) Consumer attitude of risk and benefits toward genetically modified (GM) foods in South Korea: Implications for food policy. Eng Econ 23: 189-199. Available from: http://dx.doi.org/10.5755/j01.ee.23.2.1548. |
[21] |
Gonçalves ME (2006) Risk and the governance of innovation in Europe: An introduction. Technol Forecasting Social Change 73: 1-12. doi: 10.1016/j.techfore.2005.06.008
![]() |
[22] | Sjöberg L (2008) Genetically modified food in the eyes of the public and experts. Risk Manage 10: 168-193. Available from: http://dx.doi.org/10.1057/rm.2008.2. |
[23] | Miller DM, Meek F (2004) Cost and efficacy comparison of integrated pest management strategies with monthly spray insecticide applications for German cockroach (Dictyoptera: Blattellidae) control in public housing. J Econ Entomol 97: 559-569. |
[24] | Sjakir M, Awang AH, Azima AM, et al. (2015) Learning and technology adoption impacts on farmer's productivity. Mediterr J Soc Sci 6: 126. |
[25] | Kolodinsky JM, Hogarth JM, Hilgert MA (2004) The adoption of electronic banking technologies by US consumers. Int J Bank Market 22: 238-259. |
[26] |
Ronteltap A, Van Trijp JCM, Renes RJ, et al. (2007) Consumer acceptance of technology-based food innovations: Lessons for the future of nutrigenomics. Appetite 49: 1-17. doi: 10.1016/j.appet.2007.02.002
![]() |
[27] | Gaskell G, Bauer MW, Durant J, et al. (1999) Worlds apart? The reception of genetically modified foods in Europe and the US. Science 285: 384-387. |
[28] | Talebian A, Mishra S (2018) Predicting the adoption of connected autonomous vehicles: A new approach based on the theory of diffusion of innovations. Transp Res Part C: Emerging Technol 95: 363-380. |
[29] | Lagnaoui A, Santi E, Santucci F (2004) Strategic communication for integrated pest management. Paper first presented at the Annual Conference of the International Association for Impact Assessment in Vancouver, Canada (IAIA 2004) under the conference theme of Public Involvement and Risk Management. Available from: http://siteresources.worldbank.org/ extdevcomsusdevt/Resources/ipmcommfinal.pdf. |
[30] |
Bardin B, Perrissol S, Facca L, et al. (2017) From risk perception to information selection… And not the other way round: Selective exposure mechanisms in the field of genetically modified organisms. Food Quality Preference 58: 10-17. Available from: https://doi.org/10.1016/j.foodqual.2016.12.015. doi: 10.1016/j.foodqual.2016.12.015
![]() |
[31] |
Swartz DG, Strand IE (1981) Avoidance costs associated with imperfect information: The case of kepone. Land Econ 57: 139-150. doi: 10.2307/3145782
![]() |
[32] |
De Barcellos MD, Kügler JO, Grunert KG, et al. (2010) European consumers' acceptance of beef processing technologies: A focus group study. Innovative Food Sci Emerging Technol 11: 721-732. Available from: https://doi.org/10.1016/j.ifset.2010.05.003. doi: 10.1016/j.ifset.2010.05.003
![]() |
[33] | Verbeke W, Ward RW (2001) A fresh meat almost ideal demand system incorporating negative TV press and advertising impact. Agric Econ 25: 359-374. |
[34] | Rock J (2013) Food sovereignty and the Anti-GMO movement in Ghana. Modern Ghana. Available from: http://www.modernghana.com/news/487275/1/food-sovereignty-and-the-antigmo-movement-in-ghan.html. |
[35] |
Mabaya E, Fulton J, Simiyu-Wafukho S, et al. (2015) Factors influencing adoption of genetically modified crops in Africa. Dev South Afr 32: 577-591. Available from: https://doi.org/10.1080/0376835X.2015.1044078. doi: 10.1080/0376835X.2015.1044078
![]() |
[36] | Ammar RAR, Shahrina N, Shamsuri S, et al. (2013) Communication management between organizations in a subsidized market: The Case of Paddy Fertilizer in Malaysia. Asian J Res Soc Sci Humanit 3: 1-16. |
[37] |
Dibden J, Gibbs D, Cocklin C (2013) Framing GM crops as a food security solution. J Rural Stud 29: 59-70. Available from: https://doi.org/10.1016/j.jrurstud.2011.11.001. doi: 10.1016/j.jrurstud.2011.11.001
![]() |
[38] |
Scott S (2008) East Asian experience in environmental governance: Response in a rapidly developing region‐edited by Zafar Adeel. Geogr Res 46: 126-127. doi: 10.1111/j.1745-5871.2007.00498.x
![]() |
[39] |
Horst M, Kuttschreuter M, Gutteling JM (2007) Perceived usefulness, personal experiences, risk perception and trust as determinants of adoption of e-government services in the Netherlands. Comput Human Behav 23: 1838-1852. Available from: https://doi.org/10.1016/j.chb.2005.11.003. doi: 10.1016/j.chb.2005.11.003
![]() |
[40] |
Featherman MS, Pavlou PA (2003) Predicting e-services adoption: A perceived risk facets perspective. Int J Human Comput Studies 59: 451-474. doi: 10.1016/S1071-5819(03)00111-3
![]() |
[41] | Stoner KA, Sawyer AJ, Shelton AM (1986) Constraints to the implementation of IPM programs in the USA: A course outline. Agric Ecosyst Environ 17: 253-268. |
[42] |
Vilella-Vila M, Costa-Font J (2008) Press media reporting effects on risk perceptions and attitudes towards genetically modified (GM) food. J Socio-Econo 37: 2095-2106. Available from: https://doi.org/10.1016/j.socec.2008.04.006. doi: 10.1016/j.socec.2008.04.006
![]() |
[43] |
Bearth A, Siegrist M (2016) Are risk or benefit perceptions more important for public acceptance of innovative food technologies: A meta-analysis. Trends Food Sci Technol 49: 14-23. Available from: https://doi.org/10.1016/j.tifs.2016.01.003. doi: 10.1016/j.tifs.2016.01.003
![]() |
[44] |
Vänninen I, Siipi H, Keskitalo M, et al. (2009) Ethical compatibility of GM crops with intrinsic and extrinsic values of farms: A review. Open Ethics J 3: 104-117. doi: 10.2174/1874761200903030104
![]() |
[45] | Fishbein M, Ajzen I (1975a) Belief, attitude, intention, and behavior: An introduction to theory and research. Reading, MA: Addison-Wesley. |
[46] | Ajzen I (1991) The theory of planned behavior. Organ Behav Human Decis Processes 50: 179-211. |
[47] | Burke J (2014) Biotechnology crop adoption: Potential and challenges of genetically improved crops. Encycl Agric Food Syst: 69-93. |
[48] |
Nordin SM, Noor SM, bin Md Saad MS (2014) Innovation diffusion of new technologies in the malaysian paddy fertilizer industry. Procedia-Soc Behav Sci 109: 768-778. doi: 10.1016/j.sbspro.2013.12.542
![]() |
[49] |
Valente M, Chaves C (2018) Perceptions and valuation of GM food: A study on the impact and importance of information provision. J Cleaner Prod 172: 4110-4118. Available from: https://doi.org/10.1016/j.jclepro.2017.02.042. doi: 10.1016/j.jclepro.2017.02.042
![]() |
[50] |
Aerni P (2005) Stakeholder attitudes towards the risks and benefits of genetically modified crops in South Africa. Environ Sci Policy 8: 464-476. Available from: https://doi.org/10.1016/j.envsci.2005.07.001. doi: 10.1016/j.envsci.2005.07.001
![]() |
[51] | Fishbein M, Ajzen I (1975b) Belief, attitude, intention, and behavior: An introduction to theory and research. Reading, MA: Addison-Wesley. |
[52] |
Pardo R, Midden C, Miller JD (2002) Attitudes toward biotechnology in the European Union. J Biotechnol 98: 9-24. doi: 10.1016/S0168-1656(02)00082-2
![]() |
[53] | Hair JF, Black WC, Babin BJ (2010) Multivariate data analysis (7 Eds.). Upper Saddle River, NJ: Pearson Prentice Hall. |
[54] |
Fornell C, Larcker D (1981) Evaluating structural equation models with unobservable variables and measurement errors. J Mark Res 18: 39-50. doi: 10.1177/002224378101800104
![]() |
[55] |
Chiu CM, Wang ET (2008) Understanding Web-based learning continuance intention: The role of subjective task value. Inf Manage 45: 194-201. doi: 10.1016/j.im.2008.02.003
![]() |
[56] | Bagozzi RP, Yi Y, Phillips LW (1991) Assessing construct validity in organizational research. Administrative Sci Q: 421-458. |
[57] |
Arts JWC, Frambach RT, Bijmolt THA (2011) Generalizations on consumer innovation adoption: A meta-analysis on drivers of intention and behavior. Int J Res Mark 28: 134-144. Available from: https://doi.org/10.1016/j.ijresmar.2010.11.002. doi: 10.1016/j.ijresmar.2010.11.002
![]() |
[58] |
Zhang Y, Jing L, Bai Q, et al. (2018) Application of an integrated framework to examine Chinese consumers' purchase intention toward genetically modified food. Food Quality Preference 65: 118-128. Available from: https://doi.org/10.1016/j.foodqual.2017.11.001. doi: 10.1016/j.foodqual.2017.11.001
![]() |
[59] |
Zhao X, Lynch Jr JG, Chen Q (2010) Reconsidering Baron and Kenny: Myths and truths about mediation analysis. J Consum Res 37: 197-206. Available from: https://doi.org/10.1086/651257. doi: 10.1086/651257
![]() |
[60] | Gyau A, Voss J, Spiller A, et al. (2009) Farmer acceptance of genetically modified seeds in Germany: Results of a cluster analysis. Int Food Agribusiness Manage Rev 12(1030-2016-82757): 1-20. |
[61] |
Costa-Font M, Gil JM (2009) Structural equation modelling of consumer acceptance of genetically modified (GM) food in the Mediterranean Europe: A cross country study. Food Qual Preference 20: 399-409. Available from: https://doi.org/10.1016/j.foodqual.2009.02.011. doi: 10.1016/j.foodqual.2009.02.011
![]() |
[62] |
Chen MF, Li HL (2007) The consumer's attitude toward genetically modified foods in Taiwan. Food Qual Preference 18: 662-674. doi: 10.1016/j.foodqual.2006.10.002
![]() |
[63] | Bredahl L, Grunert KG, Frewer LJ (1998) Consumer attitudes and decisionmaking with regard to genetically engineered food products. A review of the literature and a presentation of models for future research. J Consum Policy 21: 251-277. |
[64] |
Weick CW, Walchli SB (2002) Genetically engineered crops and foods: Back to the basics of technology diffusion. Technol Soc 24: 265-283. doi: 10.1016/S0160-791X(02)00008-8
![]() |
[65] |
Nelson CH (2001) Risk perception, behavior and consumer response to genetically modified organisms, toward and understanding American and European pubic reaction. Am Behav Sci 44: 1371-1388. doi: 10.1177/00027640121956737
![]() |
[66] |
Martinez-Poveda A, Brugarolas Molla-Bauza M, del Campo Gomis FJ, et al. (2009) Consumer-perceived risk model for the introduction of genetically modified food in Spain. Food Policy 34: 519-528. doi: 10.1016/j.foodpol.2009.08.001
![]() |
[67] | Amin L, Mahadi Z, Samian AL, et al. (2013a) Risk perception towards food safety issues: GM foods versus non-GM foods. J Food Agric Environ 11: 28-35. |
[68] | Onyango B, Govindasamy R (2004) Measuring US consumer preferences for genentically modified foods using choice modelling experiments: The role of price, product benefits and technology. In: American Agricultural Economics Association annual meeting, Colorado. |
[69] | Amin L, Mahadi Z, Samian AL, et al. (2013b) Risk perception towards food safety issues: GM foods versus non-GM foods. J Food Agric Environ 11: 28-35. |